Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $1.05 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.